IntelliPharmaCeutics International (IntelliPharmaCeutics International) Total Assets : $1.57 Mil (As of Aug. 2023)

View and export this data going back to 1996. Start your Free Trial

What is IntelliPharmaCeutics International Total Assets?

IntelliPharmaCeutics International's Total Assets for the quarter that ended in Aug. 2023 was $1.57 Mil.

During the past 12 months, IntelliPharmaCeutics International's average Total Assets Growth Rate was -10.30% per year. During the past 3 years, the average Total Assets Growth Rate was -28.40% per year. During the past 5 years, the average Total Assets Growth Rate was -26.90% per year. During the past 10 years, the average Total Assets Growth Rate was -3.00% per year.

During the past 13 years, IntelliPharmaCeutics International's highest 3-Year average Total Assets Growth Rate was 94.40%. The lowest was -67.10%. And the median was 2.15%.

Total Assets is connected with ROA %. IntelliPharmaCeutics International's annualized ROA % for the quarter that ended in Aug. 2023 was -457.80%. Total Assets is also linked to Revenue through Asset Turnover. IntelliPharmaCeutics International's Asset Turnover for the quarter that ended in Aug. 2023 was 0.04.

IntelliPharmaCeutics International Total Assets Historical Data

The historical data trend for IntelliPharmaCeutics International's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IntelliPharmaCeutics International Total Assets Chart

IntelliPharmaCeutics International Annual Data

Trend

Nov13

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Total Assets

Get a 7-Day Free Trial

11.47

3.80

3.39

2.10

1.43

IntelliPharmaCeutics International Quarterly Data
	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23
Total Assets	Get a 7-Day Free Trial															1.44	1.43	1.60	1.74	1.57

IntelliPharmaCeutics International Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

IntelliPharmaCeutics International's Total Assets for the fiscal year that ended in Nov. 2022 is calculated as

Total Assets	=	Total Equity (A: Nov. 2022 )	+	Total Liabilities (A: Nov. 2022 )
	=	-10.577	+	12.009
	=	1.43

IntelliPharmaCeutics International's Total Assets for the quarter that ended in Aug. 2023 is calculated as

Total Assets	=	Total Equity (Q: Aug. 2023 )	+	Total Liabilities (Q: Aug. 2023 )
	=	-12.876	+	14.442
	=	1.57

IntelliPharmaCeutics International (OTCPK:IPCIF) Total Assets Explanation

Total Assets is connected with ROA %.

IntelliPharmaCeutics International's annualized ROA % for the quarter that ended in Aug. 2023 is

ROA %	=	Net Income (Q: Aug. 2023 )	/	( (Total Assets (Q: May. 2023 )	+	Total Assets (Q: Aug. 2023 ))	/ count )
	=	-7.556	/	( (1.735	+	1.566)	/ 2 )
	=	-7.556	/	1.6505
	=	-457.80 %

Note: The Net Income data used here is four times the quarterly (Aug. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

IntelliPharmaCeutics International's Asset Turnover for the quarter that ended in Aug. 2023 is

	Asset Turnover
=	Revenue (Q: Aug. 2023 )	/	( (Total Assets (Q: May. 2023 )	+	Total Assets (Q: Aug. 2023 ))	/ count )
=	0.069	/	( (1.735	+	1.566)	/ 2 )
=	0.069	/	1.6505
=	0.04

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

IntelliPharmaCeutics International Total Assets Related Terms

Thank you for viewing the detailed overview of IntelliPharmaCeutics International's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

IntelliPharmaCeutics International (IntelliPharmaCeutics International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IntelliPharmaCeutics International Inc (OTCPK:IPCIF) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

I4AA:Germany IPCI:Canada

Address

30 Worcester Road, Toronto, ON, CAN, M9W 5X2

Website

https://www.intellipharmaceutics.com

IntelliPharmaCeutics International Inc is a pharmaceutical company. The company is engaged in the research, development, and manufacturing of novel and generic controlled-release and targeted-release oral solid dosage drugs. Its patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to the development of a range of existing and new pharmaceuticals. Its ongoing drug development programs are at various stages of development in therapeutic areas that include neurology, cardiovascular, GIT, and pain. The company's product, a generic of Focalin XR, is partnered with Par Pharmaceutical, Inc. and received FDA approval. It derives revenue from the United States.